Our partners
Genopole is France’s gold-standard biotech ecosystem. Fabmid has been selected by an expert jury to join Genopole's year-long program for early-stage start-ups for the innovativeness and potential impact on biomedical research.
Wilco is a Paris Region-based startup accelerator supporting the creation of young innovative technological enterprises. Fabmid has been selected in December 2020 to join Wilco Healthcare acceleration program. It includes a €100k non-dilutive funding and a 3-year individual support.
